Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Teva Pharmaceutical Industries Limited    TEVA

 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
10/11/2017 10/12/2017 10/13/2017 10/16/2017 10/17/2017 Date
15.76(c) 15.15(c) 14.98(c) 14.71(c) 14.74(c) Last
8 605 676 20 246 363 27 439 869 22 592 517 14 497 297 Volume
-0.82% -3.87% -1.12% -1.80% +0.20% Change
More quotes
Financials ($)
Sales 2017 22 644 M
EBIT 2017 6 282 M
Net income 2017 -
Debt 2017 34 451 M
Yield 2017 -
Sales 2018 20 624 M
EBIT 2018 5 050 M
Net income 2018 -
Debt 2018 27 776 M
Yield 2018 -
P/E ratio 2017 -
P/E ratio 2018
EV / Sales2017 2,19x
EV / Sales2018 2,08x
Capitalization 15 186 M
More Financials
Company
Teva Pharmaceutical Industries Ltd. is a global pharmaceutical company, which provides patient-centric healthcare solutions.It operates through two segments: Generic Medicines and Specialty Medicines.The Generic Medicines segment includes chemical and therapeutic equivalents of originator medicines... 
Sector
Pharmaceuticals
Calendar
11/02 | 12:00pmEarnings Release
More about the company
Latest news on TEVA PHARMACEUTICAL INDUST
10/16 TEVA PHARMACEUTICAL INDUSTRIES : "Teva unlikely to remain priced below Mylan"
10/16 TEVA PHARMACEUTICAL INDUSTRIES LIMIT : Khang & Khang LLP Announces Securities Cl..
10/16 TEVA PHARMACEUTICAL INDUSTRIES LIMIT : Levi & Korsinsky, LLP Reminds Shareholder..
10/14 DEADLINE ALERT : Brower Piven Reminds Shareholders of Approaching Deadline in Cl..
10/14 TEVA PHARMACEUTICAL INDUSTRIES LIMIT : SHAREHOLDER REMINDER: Lundin Law PC Annou..
10/13 Antares Pharma Provides XYOSTED Regulatory Update
10/12 TEVA PHARMACEUTICAL INDUSTRIES LIMIT : LEAD PLAINTIFF DEADLINE ALERT: Faruqi & F..
10/12 TEVA PHARMACEUTICAL INDUSTRIES : to Report Third Quarter 2017 Financial Results ..
10/11 TEVA PHARMACEUTICAL INDUSTRIES LIMIT : Khang & Khang LLP Announces Securities Cl..
10/11 Law Offices of Howard G. Smith Announces the Filing of a Securities Class Act..
More news
Sector news : Pharmaceuticals - NEC
08:48aDJDaimler Charts Leaner Approach -- WSJ
08:46aDJASTRAZENECA : FDA Accepts Imfinzi Supplemental Biologics License Application; Gr..
10/16DJALLERGAN : Loses Patent Fight in Federal Court
10/16DJDaimler Reshapes Company to Meet Challenges of Changing Industry -- Update
10/16 Miners provide foundation for FTSE while ConvaTec plummets
More sector news : Pharmaceuticals - NEC
Chart TEVA PHARMACEUTICAL INDUST
Duration : Period :
Teva Pharmaceutical Indust Technical Analysis Chart | TEVA | US8816242098 | 4-Traders
Income Statement Evolution
Consensus
 
Mean consensus OUTPERFORM
Number of Analysts 2
Average target price 28,0 $
Spread / Average Target 87%
Managers
NameTitle
Kåre Schultz President & Chief Executive Officer
Sol J. Barer Chairman
Carlo de Notaristefani President & CEO-Global Operations
Michael McClellan Chief Financial Officer
Michael R. Hayden Chief Scientific Officer
Sector and Competitors
1st jan.Capitalization (M$)
TEVA PHARMACEUTICAL INDUSTRIES LIMITED-58.68%15 186
JOHNSON & JOHNSON18.42%366 178
NOVARTIS13.23%225 160
ROCHE HOLDING LTD.5.20%216 764
PFIZER11.88%216 409
MERCK AND COMPANY7.68%172 887